Chronic dyspnea, defined as persistent or progressive shortness of breath, is a common symptom in patients with chronic respiratory, cardiovascular, or neuromuscular conditions and significantly impacts quality of life. Chronic dyspnea management involves a comprehensive approach aimed at relieving symptoms, improving functional capacity, and enhancing daily living activities. Assessment begins with identifying underlying causes, evaluating pulmonary and cardiac function, and reviewing comorbidities that may exacerbate breathlessness. Interventions may include pharmacological therapies, such as bronchodilators, anti-inflammatory agents, or cardiovascular medications, alongside non-pharmacological strategies like pulmonary rehabilitation, breathing exercises, and physical conditioning to strengthen respiratory muscles. Chronic dyspnea management also emphasizes patient education on energy conservation, pacing techniques, and strategies to recognize early signs of exacerbation. Supplemental oxygen and ventilatory support may be indicated for patients with severe or refractory symptoms, while multidisciplinary collaboration among pulmonologists, physiotherapists, nutritionists, and mental health professionals ensures a holistic approach. Recent research highlights the value of integrative therapies, including mindfulness, relaxation techniques, and structured exercise programs, in reducing anxiety and improving symptom perception. Continuous monitoring and adjustment of treatment plans are critical for achieving sustained relief and preventing hospitalizations. By combining targeted medical interventions, lifestyle modifications, and patient-centered education, chronic dyspnea management enhances respiratory efficiency, quality of life, and overall functional independence in individuals affected by long-term respiratory compromise.
Title : Screening questionnaires for obstructive sleep apnea: An updated systematic review
Behzad Rahmati, Isfahan University of Medical Sciences, Iran (Islamic Republic of)
Title : Improving covid 19 candidate vaccine response through probiotics and micronutrient supplementation: Evaluating the role of TLR5
Zohre Eftekhari, Biotechnology Research Center, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Iatrogenic pneumothorax following nephrectomy: Case report
Chaimae Tahiri, National University Hospital Center of Fann, Senegal